This inventor holds 2 USPTO granted patents. Top assignees: Sagami Chemical Research Center Toa Eiyo Ltd., Toa Eiyo Ltd.. Active years: 1992-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-1998
Title: Hiroyasu Sato: Innovator in Pharmaceutical Chemistry
Introduction
Hiroyasu Sato is an accomplished inventor based in Fukushima, Japan, known for his contributions to pharmaceutical chemistry. With a focus on innovative compounds that address critical health issues, Sato's work promises to enhance the treatment of circulatory organ-related diseases.
Latest Patents
Hiroyasu Sato holds two noteworthy patents. The first patent involves a substituted cyclic amine compound along with its production process. This compound is represented by a specific general formula and is recognized for its potential in preventing and treating circulatory organ-related diseases such as hypertension, ischemic heart disease, cerebrovascular disease, and peripheral circulatory disease.
His second patent pertains to cis-bicyclo[4,3.0]non-2-ene derivatives, which include a detailed formula for a compound that can be critical in various pharmaceutical applications. The structural elements of this compound allow for diverse substituents and functionalities, making it versatile for medicinal chemistry.
Career Highlights
Throughout his career, Hiroyasu Sato has worked with notable companies such as Toa Eiyo Ltd. and the Sagami Chemical Research Center. His experience in these esteemed organizations has contributed to his expertise in chemical synthesis and innovation in the pharmaceutical field.
Collaborations
Sato has collaborated with several professionals, including Shin-ichi Yamada and Kentaro Kogi. These partnerships have played a vital role in advancing his research and development efforts in drug formulation and synthesis.
Conclusion
Hiroyasu Sato continues to pave the way in pharmaceutical innovation with his patented works and collaborations. His developments in substituted cyclic amines and bicyclic derivatives offer promising avenues for addressing critical health challenges associated with circulatory system diseases. As he progresses in his career, Sato's contributions are sure to have a significant impact on medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile